Fatty Liver: all 1,462 studies
Page 14 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese ChildrenCompletedNCT01682655
- Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver DiseaseStatus unknownNCT01680003Phase 2
- The Clinical Trail Of NAFLD Treated By Traditional Chinese MedicineCompletedNCT01677325Phase 1
- Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy ControlsCompletedNCT01674972
- Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant NeoplasmCompletedNCT01657773
- Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic SteatohepatitisCompletedNCT01650181Phase 4
- A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver ResectionCompletedNCT01645852Not applicable
- Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family MembersStatus unknownNCT01643512
- Association of Non-alcoholic Fatty Liver Disease and Coronary Artery DiseaseStatus unknownNCT01638832Not applicable
- Genetic Studies of Non-Alcoholic Fatty Liver DiseaseTerminatedNCT01629095
- Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic SteatohepatitisStatus unknownNCT01623024Phase 3
- The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT01619215
- Atorvastatin, L-Carnitine and Non-Alcoholic SteatohepatitisStatus unknownNCT01617772Phase 2
- Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin DCompletedNCT01571063Phase 2
- Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver DiseaseCompletedNCT01556113Not applicable
- Glucomannan Effects on Children With Non-alcoholic Fatty Liver DiseaseCompletedNCT01553500Phase 2
- Ursodeoxycholic Acid in Bariatric SurgeryCompletedNCT01548079Not applicable
- Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in ChildrenCompletedNCT01547910Phase 2
- Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus AtorvastatinStatus unknownNCT01544751Not applicable
- Multiparametric MR for Rapid Imaging Assessment of the LiverStatus unknownNCT01543646
- A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated SteatosisTerminatedNCT01523639Phase 2
- Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT01511523Not applicable
- Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without DiabetesCompletedNCT01492283
- Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty LiverCompletedNCT01477307
- Prognostic Indicators as Provided by the EPIC ClearViewCompletedNCT01476995
- Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT01472120
- Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic SteatohepatitisWithdrawnNCT01466894Phase 2
- Resveratrol in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT01464801Not applicable
- Clinical Study of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content in Dialysis PatientsStatus unknownNCT01457625
- Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver DiseaseCompletedNCT01446276Not applicable
- Supplementation of Probiotics and Fruit Fibre to Patients With Fatty LiverTerminatedNCT01423630Not applicable
- Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT01418027Phase 3
- Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASHTerminatedNCT01406704Phase 4
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 DiabetesCompletedNCT01399645Phase 2
- Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic SteatohepatitisWithdrawnNCT01384578Phase 3
- Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT01373554Phase 2
- Effect of Dietary Macronutrient CompositionCompletedNCT01371396Not applicable
- Meta-analyses of Fructose and Cardiometabolic RiskStatus unknownNCT01363791
- Regression of Myocardial Steatosis by NebivololCompletedNCT01358409Early Phase 1
- Dietary Protein and Hepatic Fat AccumulationCompletedNCT01354626Not applicable
- Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver DiseaseCompletedNCT01327443Not applicable
- Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic SteatohepatitisCompletedNCT01324414
- Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!CompletedNCT01317576Not applicable
- Association Between Non-alcoholic Fatty Liver Disease and Iron StatusStatus unknownNCT01307254
- Effect of Fructose Reduction on Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome in Overweight ChildrenStatus unknownNCT01306396Not applicable
- Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary AtherosclerosisStatus unknownNCT01282892
- Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical TrialWithdrawnNCT01279434Not applicable
- The Impact of Deferasirox on Non-Alcoholic-SteatohepatitisCompletedNCT01278056Phase 1/2
- The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver DiseaseCompletedNCT01277237Phase 3
- A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT01277094Phase 1
- The Role of Resistance Training in Non Alcoholic Fatty Liver DiseaseCompletedNCT01264198Not applicable
- Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose ProductionCompletedNCT01262326Not applicable
- Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 DiabetesTerminatedNCT01260246Not applicable
- Selenoprotein P and Non-alcoholic Fatty Liver DiseaseCompletedNCT01257685
- Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic HepatopathyStatus unknownNCT01246388
- Liraglutide Efficacy and Action in Non-Alcoholic SteatohepatitisCompletedNCT01237119Phase 2
- Trial of Hepaguard® in Adults With Nonalcoholic SteatohepatitisCompletedNCT01210989Not applicable
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)CompletedNCT01208649Phase 4
- Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic SyndromeCompletedNCT01205087Phase 2
- Elevated Circulating FFA and Intrahepatic Lipid ContentCompletedNCT01177332Not applicable
- A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT01167088Phase 2
- Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT01148576Phase 4
- Longitudinal Study of Mitochondrial HepatopathiesSuspendedNCT01148550
- Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT01147523Phase 2
- The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT01139632
- Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)CompletedNCT01110577
- Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver BiopsyCompletedNCT01100398
- Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic SteatohepatitisCompletedNCT01094158Phase 2
- Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT01084486Phase 1/2
- Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT01083992Not applicable
- The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic SteatohepatitisCompletedNCT01068444Phase 2
- Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)CompletedNCT01056133Phase 2
- Anti-Fibrotic Effects of Losartan In Nash Evaluation StudyCompletedNCT01051219Phase 3
- Role of Dietary Fatty Acids in Fatty Liver and Insulin ResistanceCompletedNCT01038102Not applicable
- Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2CompletedNCT01030484
- Bovine Colostrum for Patients With Non Alcoholic Fatty Liver DiseaseCompletedNCT01016418Phase 1/2
- Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass SurgeryCompletedNCT01007955
- The Effect of Protandim on Non-alcoholic SteatohepatitisCompletedNCT00977730Not applicable
- Regulation of FGF21 by Nutritional ChallengesCompletedNCT00968747Not applicable
- Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT00941642Phase 4
- A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With PsoriasisCompletedNCT00930384
- Effect of Diet Composition on Liver Fat and Glucose MetabolismCompletedNCT00930371Not applicable
- Identification of Protective and Worsening Steatohepatitis (NASH) FactorsStatus unknownNCT00914446Not applicable
- Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected PersonsCompletedNCT00889577
- Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery CandidatesCompletedNCT00887393Not applicable
- Fatty Liver and Ectopic Fat in Overweight and Obese PatientsCompletedNCT00886301Not applicable
- Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00885313Phase 1/2
- Effect of Dietary and Life Style Modification on Post Liver Transplant ObesityTerminatedNCT00878592Not applicable
- A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver DiseaseCompletedNCT00870077Not applicable
- Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and PrebioticsCompletedNCT00870012Not applicable
- Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver DiseaseCompletedNCT00868933Not applicable
- Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese WomenCompletedNCT00862433Phase 1
- Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy VolunteersCompletedNCT00856869Phase 1/2
- Fatty Liver in Inflammatory Bowel Disease (IBD) PatientsTerminatedNCT00855907
- Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) InfectionStatus unknownNCT00842205Not applicable
- Effects of Coffee on Hepatic Steatosis Induced by a High Fructose DietCompletedNCT00827450Not applicable
- Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for OverweightCompletedNCT00823277
- Efficacy and Safety of Diamel in Patients With Nonalcoholic SteatohepatitisCompletedNCT00820651Phase 3
- The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT00819338Phase 2
- Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT00816465Phase 1